M4MM

atai Life Sciences Reports Q2 2024 Financial Results

LOS ANGELES- atai Life Sciences, a biopharmaceutical company focused on transforming mental health treatment, announced its financial results for the second quarter of 2024 along with updates on its clinical pipeline. The company highlighted significant ...

Willow Biosciences Posts Record Revenue in Q2

LOS ANGELES- Willow Biosciences Inc. a synthetic biology company specializing in pharmaceutical ingredients, reported record revenue of $1 million for the second quarter of 2024, a 660% increase compared to the same period last year. ...

Week’s In Review: Federal Policy Uncertainty Continues to Challenge U.S. Cannabis Industry; LeafLink Acquires Leaf Trade to Enhance Cannabis Wholesale Platform; Canopy Growth Appoints New CEO Amid Financial Challenges; New York’s Legal Cannabis Sales Approach $1 Billion Milestone

LOS ANGELES — Welcome to the far too-exciting world of cannabis and psychedelics, where it’s a tale of two markets with some states doing amazingly well. And some, well...they're not doing so well (hello New ...

Week’s In Review: Trump’s Return to Office: What it Means for the Cannabis Industry; Planet 13 Launches Initiative to Support Florida Veterans and First Responders with Medical Cannabis Access; Mixed Results for Cannabis Initiatives in U.S. States; Texas Voters Approve Local Cannabis Decriminalization in Dallas, Bastrop, and Lockhart

LOS ANGELES — Welcome to the far too-exciting world of cannabis and psychedelics, where it’s a tale of two markets with some states doing amazingly well. And some, well...they're not doing so well (hello New ...

Week’s In Review: Criticism Mounts Over New York’s Social Equity Cannabis Fund for High Costs and Limited Impact; Arizona to Launch Recreational Cannabis Home Delivery; DeSantis Uses Opioid Settlement Funds for Anti-Cannabis Ads Ahead of Ballot Initiative

LOS ANGELES — Welcome to the far too-exciting world of cannabis and psychedelics, where it’s a tale of two markets with some states doing amazingly well. And some, well...they're not doing so well (hello New ...

Subscribe To Our Newsletter